Clinical Trial Update: Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of lenalidomide after reduced-intensity allogeneic stem cell transplantation in relapsed multiple myeloma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED